Skip to main content
Livermore
Livermore
ZHEN

Editas Medicine, Inc.

EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001650664

In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Editas Medicine, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of EDIT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders2072195−10
Shares51.1M319.8K44.0M−6.73M (−13.3%)
Value$64.8M$406.1K$51.0M−$13.4M (−20.8%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Editas Medicine, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to EDIT in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC316,614$367.3K0.00%
Marshall Wace, LLP242,376$281.2K0.00%
Cerity Partners LLC49,060$56.9K0.00%
State of Wyoming44,358$51.5K0.01%
SCS Capital Management LLC35,000$40.6K0.00%
Mariner, LLC21,781$25.3K0.00%
Patriot Financial Group Insurance Agency, LLC20,500$23.8K0.00%
CIBC World Markets Corp18,390$21.3K0.00%
Farringdon Capital, Ltd.16,327$18.9K0.01%
Pallas Capital Advisors LLC16,275$18.9K0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH13,100$15.2K0.00%
Buckingham Strategic Partners11,002$12.8K0.00%
Atom Investors LP10,275$11.9K0.00%
Coldstream Capital Management Inc1,582$1.84K0.00%
Stone House Investment Management, LLC1,000$1.16K0.00%
Tradewinds Capital Management, LLC700$8120.00%
Clear Street Markets LLC178$2060.00%
GHP Investment Advisors, Inc.164$1910.00%
SRS Capital Advisors, Inc.150$1740.00%
Global Wealth Strategies & Associates125$1450.00%
Boston Private Wealth LLC95$1100.00%
Curio Wealth, LLC1$980.00%
MorganRosel Wealth Management, LLC40$460.00%
Sandy Spring Bank2$30.00%

Sold out (34)

Institutions that held Editas Medicine, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of EDIT in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Balyasny Asset Management LLC1,300,604$1.65M
Monaco Asset Management SAM1,069,732$1.36M
Woodline Partners LP838,419$1.06M
Jacobs Levy Equity Management, Inc708,409$899.7K
Tang Capital Management LLC400,000$508.0K
Ameriprise Financial Inc227,609$289.1K
Squarepoint Ops LLC189,462$240.6K
Aristides Capital LLC131,900$167.5K
Public Employees Retirement System of Ohio111,716$141.9K
Engineers Gate Manager LP79,159$100.5K
Point72 (DIFC) Ltd74,409$94.5K
Virtu Financial LLC70,980$90.0K
Verition Fund Management LLC42,074$53.4K
Point72 Asia (Singapore) Pte. Ltd.36,343$46.2K
Freestone Grove Partners LP36,126$45.9K
International Assets Investment Management, LLC31,157$40.8K
Scientech Research LLC24,353$30.9K
Sherbrooke Park Advisers LLC15,024$19.1K
Walleye Capital LLC11,646$14.8K
Victory Capital Management Inc10,115$12.8K
Alpha Wealth Funds, LLC10,000$12.0K
Cubist Systematic Strategies, LLC7,115$9.04K
R Squared Ltd2,740$3.48K
Synergy Financial Management, LLC1,000$3.41K
Kings Path Partners LLC1,000$1.27K
Washington Trust Co442$561
Caitong International Asset Management Co., Ltd286$363
Nelson, Van Denburg & Campbell Wealth Management Group, LLC190$241
Blue Bell Private Wealth Management, LLC139$177
Massmutual Trust Co FSB120$152
Beaird Harris Wealth Management, LLC80$102
Proequities, Inc.75$100
GPS Wealth Strategies Group, LLC2$3
Lazard Asset Management LLC76$0

Not filed for Q1 2025 yet (2)

Institutions that held Editas Medicine, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EDIT in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC316,614$402.1K
WR Wealth Planners, LLC3,175$4.03K